Drug-resistant tuberculosis in Israel: Risk factors and treatment outcomes

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 10, 2014, Pages 1195-1201

  Mor, Z ^a   Goldblatt, D ^a   Kaidar Shwartz, H ^a   Cedar, N ^a   Rorman, E ^a   Chemtob, D ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

Drug resistance; Immigration; Laboratory; Mycobacteriology; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISRAEL; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIGRANT; MULTIDRUG RESISTANT TUBERCULOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SPUTUM SMEAR; TREATMENT OUTCOME; USSR; ADOLESCENT; CHILD; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HIV INFECTIONS; INFANT; MICROBIOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; ISRAEL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84907175711     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0192     Document Type: Article

References (30)

1. World Health Organization Global tuberculosis report, 2013 WHO/HTM/TB/2013.11 Geneva, Switzerland: WHO, 2012 http://apps.who.int/i r i s/b i t s tream/10665/91355/1/9789241564656-eng.pdf Accessed July 2014.
2. Taylor J P, Bergmire-Sweet D, Suarez L.Epidemiology of drugresistant tuberculosis in Texas Am J Epidemiol 1999; 149: 359-365.
3. Kant S, Maurya A K, Kushwaha R A, Nag V L, Prasad R.Multidrug-resistant tuberculosis: an iatrogenic problem Biosci Trends 2010; 4: 48-55.
4. Aziz M A, Wright A, Laszlo A, et al Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance): an updated analysis Lancet 2006; 368: 2142-2154.
5. Zignol M, van Gemert W, Falson D, Sismanidis C, Glaziou P.Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 Bull World Health Organ 2012; 90: 111-119D.
6. European Centre for Disease Prevention and Control/WHO Regional Office for Europe Tuberculosis surveillance and monitoring in Europe 2013 Stockholm, Sweden: ECDC, 2013 http://www.ecdc.europa.eu/en/publications/Publications/Tuberculosis-surveillance-monitoring-2013.pdf Accessed July 2014.
7. Mor Z, Pinsker G, Cedar N, Lidji M, Grotto I.Adult tuberculosis in Israel and migration: Trends and challenges between 1999 and 2010 Int J Tuberc Lung Dis 2012; 16: 1613-1618.
8. Veen J, Raviglione M, Rieder H L, et al Standardised tuberculosis treatment outcome in Europe Eur Respir J 1998; 12: 505-510.
9. Mor Z, Pinsker G, Cedar N, Lidji M, Grotto I.Epidemiology of extra-pulmonary tuberculosis in Israel, 1999-2010 Int J Tuberc Lung Dis 2013; 17: 229-233.
10. Kent P T, Kubica G P.Public health mycobacteriology: a guide for the level III laboratory Atlanta, GA, USA: Centers for Disease Control, Public Health Services, Department of Health and Human Services, 1985.
11. Marks J.A system for the examination of tubercle bacilli and other mycobacteria Tubercle 1976; 57: 207-225.
12. Collins CH, Grange JM, YatesMD Tuberculosis bacteriology organisation and practice 2nd ed Oxford, UK; Butterworth-Heinemann, 1997.
13. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control Wkly Epidemiol Rec 2006; 81: 430-432.
14. Lavy A, Mates A.A 10-year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance Isr J Med Sci 1994; 30: 805-810.
15. Centers for Disease Control and Pr evention Reported tuberculosis in the United States, 2011 Atlanta, GA, USA: US Department of Health and Human Services, CDC, 2012 http://www.cdc.gov/tb/statistics/reports/2011/pdf/report2011.pdf Accessed July 2014.
16. Bendayan D, Hendler A, Polansky V, Weinberger M.Outcome of hospitalized MDR-TB patients: Israel 2000-2005 Eur J Clin Microbiol Infect Dis 2011; 30: 375-379.
17. Gilad J, Borrer A, Riesenberg K, Peled N, Schlaeffer F.Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997 Chest 2000; 17: 738-743.
18. Sosna J, Shulimzon T, Rozenman J, et al Drug-resistant pulmonary tuberculosis in Israel, a society of immigrants: 1985-1994 Int J Tuberc Lung Dis 1999; 3: 684-694.
19. Chemtob D, Weiler-Ravell D.Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases Int J Tuberc Lung Dis 2000; 4: 990-991.
20. Eker B, Ortmann J, Migliori G B, et al Multi-drug and extensively drug-resistant tuberculosis, Germany Emerg Infect Dis 2008; 14: 1700-1706.
21. Papaventsis D, Nikolaou S, Karabela S, et al Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009 Euro Surveill 2010; 15: pii=19614.
22. Wells C D, Cegielski J P, Nelson L J, et al HIV infection and multidrug-resistant tuberculosis: the perfect storm J Infect Dis 2006; 196 (Suppl 1): S86-S107.
23. Central Bureau of Statistics Statistical Abstract of Israel No 63 Jerusalem, Israel: CBS, 2012 http://www.cdc.gov/tb/statistics/reports/2011/default.htm Accessed July 2014.
24. Balabanova Y, Radiulyte B, Davidaviciene E, et al Risk factors for drug-resistant tuberculosis patients in Lithuania, 2002-2008 Eur Respir J 2012; 39: 1266-1269.
25. World Health Organization The global plan to stop TB, 2011-2015: transforming the fight towards elimination of tuberculosis WHO/HTM/TB/2009.426 Geneva, Switzerland: WHO, 2009.
26. Mor Z, Leventhal A, Diacon A, Scoch D.Tuberculosis screening in immigr ants from high-prevalence countries: Interview first or chest radiograph first? Respirology 2013; 18: 432-438
27. World Health Organization Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global re port on surveillance and response WHO/HTM/TB/2010.3 Geneva Switzerland: WHO 2010 http://whqlibdoc.who.int/publications/2010/9789241599191-eng.pdf Accessed July 2014.
28. Shao Y, Yang D, XuW, et al Ep idemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead BMC Public Health 2011; 11: 1110.
29. Mor Z, Lerman Y, Leventhal A.Evaluating tuberculosis preimmigration process in Ethiopian immigrants to Israel Eur Respir J 2008; 32: 413-418.
30. Carvalho A C C, Migliori G B, Cirillo D M.Tuberculosis in Europe: a problem of drug resistance or much more? Expert Rev Res Med 2010; 4: 189-200.